What telogen effluvium is
Hair grows in cycles. At any moment most follicles are in the growth phase and a minority are in the resting phase, after which the hair sheds and the follicle starts again. A significant physiological stress can push an unusually large number of follicles into the resting phase at once.
The shedding then happens when that resting phase ends, which is why the timing is so counterintuitive: the hair falls out two to four months after the event that caused it, not during it. People routinely conclude that the shedding started for no reason, because by then the rapid weight loss that triggered it feels like old news.
- 2 to 4 months
- Typical delay between the trigger and the shedding starting
- 3 to 6 months
- Typical duration of the shedding phase
- 6 to 12 months
- Typical time for density to visibly recover afterwards
The hair usually comes back. Telogen effluvium is a shedding of hairs that were going to cycle anyway, in a synchronised burst, not a destruction of follicles. Regrowth is slow enough to be frustrating, and new growth often appears first as short baby hairs around the hairline.
Why weight loss triggers it
Hair follicles are among the fastest-dividing tissues in the body and correspondingly sensitive to a resource shortfall. The trigger here is not the drug molecule, it is the rapid and substantial energy deficit the drug enables. The same shedding is well documented after bariatric surgery, crash dieting, serious illness, childbirth and major surgery.
Two things follow from that, and they are the useful part of understanding the mechanism:
- Faster loss makes it more likely. The rate of loss matters more than the total, which is one of the few practical levers there is.
- Nutritional adequacy matters within that deficit. Very low protein intake, and low iron, zinc or vitamin D, are all associated with hair shedding independently, and all of them are easy to fall into when appetite suppression cuts total intake sharply.
What actually influences it
There is no intervention that reliably stops telogen effluvium once it has started, because the follicles concerned entered the resting phase months ago. What can be influenced is the size of any further wave and the quality of the regrowth.
- Protein intake. The single most common shortfall on these drugs, and one that matters for hair, muscle and recovery alike. The muscle and protein page covers how to get it in on a much smaller appetite.
- Ask about iron, ferritin, zinc, vitamin D and thyroid function. Low ferritin in particular is a common and treatable contributor, and thyroid disease produces hair loss of its own and is worth excluding rather than assuming.
- The rate of loss. If shedding is significant and loss is very fast, that is a legitimate thing to raise at a review. Slowing the descent is a real option, and it is a prescriber decision.
- Time. Unsatisfying and true. The shedding phase runs its course and then stops.
- Be gentle with what is there. Tight styles, heat and aggressive brushing do not cause telogen effluvium but they add avoidable breakage to a head of hair that is already thinner.
When it is not telogen effluvium
The pattern above is specific, and things that do not match it deserve a proper assessment rather than being filed under expected side effects.
Patchy, defined bald spots
Telogen effluvium is diffuse thinning across the whole scalp, not discrete circular patches. Patches suggest a different diagnosis, such as alopecia areata, and should be seen.
Scalp pain, scaling, redness or itching
Shedding with an inflamed or symptomatic scalp is not the usual picture and needs a look, since scarring alopecias are treatable early and not later.
Shedding that runs beyond a year
Chronic telogen effluvium exists, but a shedding phase that does not settle should prompt bloods and a diagnosis rather than continued waiting.
A receding hairline or crown thinning
Pattern hair loss is a different process with different treatments. Weight loss can unmask it or make it more noticeable, and it does not resolve on its own the way effluvium does.
This page describes a common and well-documented pattern; it is not a diagnosis. Anything that does not fit is worth a professional opinion.
What to track
This is one of the clearest cases where a record answers a question that memory cannot.
- When the shedding started, as a date. Everything about interpreting it depends on the interval from the trigger.
- Your rate of weight loss in the two to four months before it started. That is the window that caused it, not the current one.
- Your dose history, so you can see whether it followed a particular step up.
- Any bloods you have had done, and when, so a repeat is comparable.
- When the shedding slowed. It is the fact you will want at the next review, and nobody remembers it accurately.
Penwise records symptoms and notes against dates and doses, so the two-to-four-month lag that makes this confusing becomes something you can simply look at. The side effects timeline covers what lands when across the whole course, and the weight loss timeline covers the rate of loss itself.
Match the effect to the month that caused it
Symptoms, doses and weight on one timeline, so a delayed effect is traceable. Free core tracker, no account.
Common questions
Does Ozempic or Mounjaro cause hair loss?
When does hair loss start on a GLP-1?
How long does GLP-1 hair loss last?
Will my hair grow back after stopping or after the weight loss slows?
Can anything stop the shedding once it starts?
Does taking more protein help with hair loss on these drugs?
Sources
Every factual claim on this page traces to the product information a regulator publishes, or to a published trial. Links open on the site of whoever issued the document.
- Telogen Effluvium StatPearls, NCBI Bookshelf
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) New England Journal of Medicine, 2021
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) New England Journal of Medicine, 2022
Penwise is a tracking and education tool, not a medical device. Nothing on this page is medical advice, a diagnosis or a recommendation to start, stop or change a dose. Dosing decisions belong to you and your clinician. Ozempic, Wegovy, Rybelsus, Saxenda and Victoza are trademarks of Novo Nordisk; Mounjaro, Zepbound and Trulicity are trademarks of Eli Lilly. Penwise is not affiliated with, endorsed by or connected to either company.